Veterinary Medicines

FIXR PRRS inac

Authorised
  • Porcine reproductive and respiratory syndrome virus, type 2, strain Bio-61, Inactivated
  • Porcine reproductive and respiratory syndrome virus, type 1, strain Bio-60, Inactivated
Download as PDF

Product identification

Medicine name:
FIXR PRRS inac
FIXR PRRS inac, emulsie voor injectie voor varkens
Active substance:
  • Porcine reproductive and respiratory syndrome virus, type 2, strain Bio-61, Inactivated
  • Porcine reproductive and respiratory syndrome virus, type 1, strain Bio-60, Inactivated
Target species:
  • Pig (sow)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine reproductive and respiratory syndrome virus, type 2, strain Bio-61, Inactivated
    1.00
    unit(s)
    /
    1.00
    Dose
  • Porcine reproductive and respiratory syndrome virus, type 1, strain Bio-60, Inactivated
    1.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (sow)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 1 × 10 ml (1 x 5 doses ) - glass vials hydrolytic class I or plastic HDPE vials closed with chlorobutyl rubber stoppers, sealed with aluminum caps in a cardboard box.
  • 10 x 10 ml (10 x 5 doses) - glass vials hydrolytic class I or plastic HDPE vials closed with chlorobutyl rubber stoppers, sealed with aluminum caps in a cardboard box with a grid or PVC box.
  • 1 × 50 ml (1 x 25 doses) - glass vials hydrolytic class II or plastic HDPE vials closed with chlorobutyl rubber stoppers, sealed with aluminum caps in a cardboard box.
  • 1 × 100 ml (1 x 50 doses) - glass vials hydrolytic class II or plastic HDPE vials closed with chlorobutyl rubber stoppers, sealed with aluminum caps in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kernfarm B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 125906
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0342/001
Concerned member states:
  • Belgium

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."